Latest News
Press Releases
IAVI and Scripps Research Join Efforts with NIH to Expedite Development of Globally Accessible and Affordable HIV Antibody Combination Products
May 26, 2020IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
April 23, 2020COVID-19ワクチン開発のための日本政府による世銀への拠出表明は国際保健改善の模範である、とIAVIが歓迎
April 22, 2020Japan's Commitment to Contribute to the World Bank for COVID-19 Vaccine Research Sets Example and Will Advance Global Health, IAVI Says
April 1, 2020IAVI Welcomes W. Ripley Ballou, M.D., as ADVANCE Program Lead and Principal Investigator
More COVID-19 News
Surveying the HIV Vaccine and Cure Landscape at AIDS 2020 Virtual
Thumbi Ndung'u, Ph.D., provides a view of current strategies for HIV vaccine and cure design
June 15, 2020
Powerful antibodies isolated from recovered donors protect against COVID-19 disease in an animal model
Findings offer promise for accelerated development of antibody-based prevention and treatment for COVID-19
June 5, 2020
Exploring the links between HIV and TB research and COVID-19
Summarizing the impact of COVID-19 on ongoing HIV and TB prevention research
June 3, 2020
Watch IAVI Experts Discuss Accelerating COVID-19 Vaccine Development with Merck
Mark Feinberg and Swati Gupta introduce viewers to the COVID-19 vaccine candidate, which uses the same technology as Merck’s Ebola vaccine.
May 27, 2020
Webinar Series Explores Community Engagement During COVID-19 and Beyond
Seventh edition of webinar series tackles community engagement in a time of social distancing.
May 26, 2020
IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
New collaboration to leverage complementary expertise and capabilities with rVSV technology to advance novel vaccine candidate
April 23, 2020
COVID-19ワクチン開発のための日本政府による世銀への拠出表明は国際保健改善の模範である、とIAVIが歓迎
Japan's commitment to contribute to the World Bank for COVID-19 vaccine research sets example and will advance global health, IAVI says (in Japanese).
April 22, 2020
Japan's Commitment to Contribute to the World Bank for COVID-19 Vaccine Research Sets Example and Will Advance Global Health, IAVI Says
Government of Japan, in partnership with the World Bank, commits funds to COVID-19 vaccine development.
March 30, 2020
The Effects of COVID-19 on IAVI Clinical Programs
IAVI's response to the COVID-19 pandemic
Features
Contributing to HIV Vaccine Research in Africa: USAID-Funded Science Capacity Building Partnership with IAVI
July 21, 2020Surveying the HIV Vaccine and Cure Landscape at AIDS 2020 Virtual
June 22, 2020Donor Spotlight: Government of Japan
June 15, 2020Powerful antibodies isolated from recovered donors protect against COVID-19 disease in an animal model
June 5, 2020Exploring the links between HIV and TB research and COVID-19
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
